Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study of zoledronic acid and alendronate in the treatment of postmenopausal osteoporosis
ChiCTR2100045485Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of zoledronic acid and alendronate in postmenopausal osteoporosis (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Total hip joint T value, Bone trabecular fraction of lumbar spine (TBS) and 2 more. Started May 2021; status: recruiting.
02
Drugs
zoledronic acidalendronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on ChiCTR2100045485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045485.